Analysts Set Expectations for X4 Pharmaceuticals, Inc.'s FY2027 Earnings (NASDAQ:XFOR)

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Get Rating) – Investment analysts at HC Wainwright boosted their FY2027 EPS estimates for shares of X4 Pharmaceuticals in a research note issued to investors on Friday, May 5th. HC Wainwright analyst S. Ramakanth now expects that the company will earn $0.29 per share for the year, up from their […]

Related Keywords

Adams Mostafa , ,Pharmaceuticals Trading Down ,Pharmaceuticals Daily ,Nasdaq ,Cantor Fitzgerald ,Management Company ,Pharmaceuticals Inc ,Bain Capital Life Sciences Investors ,Vanguard Group Inc ,Get Rating ,Trading Down ,Capital Life Sciences Investors ,X4 Pharmaceuticals ,Nasdaq Xfor ,Wexfor ,Medical ,Earnings Estimates ,Hc Wainwright ,